vs

Side-by-side financial comparison of HIVE Digital Technologies Ltd. (HIVE) and RCM TECHNOLOGIES, INC. (RCMT). Click either name above to swap in a different company.

HIVE Digital Technologies Ltd. is the larger business by last-quarter revenue ($93.1M vs $86.5M, roughly 1.1× RCM TECHNOLOGIES, INC.). RCM TECHNOLOGIES, INC. runs the higher net margin — 7.1% vs -98.1%, a 105.1% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 12.4%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 9.6%).

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

Exela Technologies, Inc. is an American business process automation ("BPA") company. It was created with the merger of SourceHOV LCC, Novitex Holdings, Inc. and Quinpario Acquisition Corp. 2.

HIVE vs RCMT — Head-to-Head

Bigger by revenue
HIVE
HIVE
1.1× larger
HIVE
$93.1M
$86.5M
RCMT
Growing faster (revenue YoY)
HIVE
HIVE
+206.1% gap
HIVE
218.6%
12.4%
RCMT
Higher net margin
RCMT
RCMT
105.1% more per $
RCMT
7.1%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
9.6%
RCMT

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
HIVE
HIVE
RCMT
RCMT
Revenue
$93.1M
$86.5M
Net Profit
$-91.3M
$6.1M
Gross Margin
-27.1%
28.1%
Operating Margin
9.2%
Net Margin
-98.1%
7.1%
Revenue YoY
218.6%
12.4%
Net Profit YoY
-234.0%
112.9%
EPS (diluted)
$-0.38
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIVE
HIVE
RCMT
RCMT
Q1 26
$86.5M
Q4 25
$93.1M
Q3 25
$87.3M
$70.3M
Q2 25
$45.6M
$78.2M
Q1 25
$84.5M
Q4 24
$29.2M
$76.9M
Q3 24
$22.6M
$60.4M
Q2 24
$32.2M
$69.2M
Net Profit
HIVE
HIVE
RCMT
RCMT
Q1 26
$6.1M
Q4 25
$-91.3M
Q3 25
$-15.8M
$2.3M
Q2 25
$35.0M
$3.8M
Q1 25
$4.2M
Q4 24
$68.2M
$2.9M
Q3 24
$80.0K
$2.7M
Q2 24
$-18.3M
$3.8M
Gross Margin
HIVE
HIVE
RCMT
RCMT
Q1 26
28.1%
Q4 25
-27.1%
Q3 25
4.7%
27.6%
Q2 25
-13.6%
28.5%
Q1 25
26.0%
Q4 24
-43.7%
28.0%
Q3 24
-66.1%
29.6%
Q2 24
-7.4%
28.9%
Operating Margin
HIVE
HIVE
RCMT
RCMT
Q1 26
9.2%
Q4 25
Q3 25
5.6%
Q2 25
8.4%
Q1 25
7.8%
Q4 24
8.2%
Q3 24
7.3%
Q2 24
8.4%
Net Margin
HIVE
HIVE
RCMT
RCMT
Q1 26
7.1%
Q4 25
-98.1%
Q3 25
-18.1%
3.2%
Q2 25
76.8%
4.8%
Q1 25
5.0%
Q4 24
233.2%
3.7%
Q3 24
0.4%
4.5%
Q2 24
-56.7%
5.4%
EPS (diluted)
HIVE
HIVE
RCMT
RCMT
Q1 26
$0.80
Q4 25
$-0.38
Q3 25
$-0.07
$0.30
Q2 25
$0.18
$0.50
Q1 25
$0.54
Q4 24
$0.52
$0.38
Q3 24
$0.00
$0.35
Q2 24
$-0.17
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIVE
HIVE
RCMT
RCMT
Cash + ST InvestmentsLiquidity on hand
$2.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$559.3M
$46.0M
Total Assets
$624.0M
$134.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIVE
HIVE
RCMT
RCMT
Q1 26
$2.9M
Q4 25
Q3 25
$1.3M
Q2 25
$5.5M
Q1 25
$5.2M
Q4 24
$40.5M
$4.7M
Q3 24
$31.7M
$3.2M
Q2 24
$3.5M
Stockholders' Equity
HIVE
HIVE
RCMT
RCMT
Q1 26
$46.0M
Q4 25
$559.3M
Q3 25
$624.6M
$41.4M
Q2 25
$560.5M
$37.8M
Q1 25
$34.6M
Q4 24
$430.9M
$33.5M
Q3 24
$275.5M
$30.0M
Q2 24
$268.6M
$28.5M
Total Assets
HIVE
HIVE
RCMT
RCMT
Q1 26
$134.4M
Q4 25
$624.0M
Q3 25
$693.0M
$129.8M
Q2 25
$628.7M
$135.6M
Q1 25
$121.0M
Q4 24
$478.6M
$132.1M
Q3 24
$334.7M
$125.5M
Q2 24
$118.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIVE
HIVE
RCMT
RCMT
Operating Cash FlowLast quarter
$46.0M
$19.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.11×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIVE
HIVE
RCMT
RCMT
Q1 26
$19.0M
Q4 25
$46.0M
Q3 25
$-10.6M
$-1.3M
Q2 25
$10.2M
$-7.9M
Q1 25
$16.7M
Q4 24
$-28.5M
$-1.6M
Q3 24
$-2.2M
$-4.3M
Q2 24
$-4.4M
$5.7M
Free Cash Flow
HIVE
HIVE
RCMT
RCMT
Q1 26
Q4 25
Q3 25
$-1.8M
Q2 25
$-8.4M
Q1 25
$16.2M
Q4 24
$-55.5M
$-2.6M
Q3 24
$-34.7M
$-4.9M
Q2 24
$5.3M
FCF Margin
HIVE
HIVE
RCMT
RCMT
Q1 26
Q4 25
Q3 25
-2.5%
Q2 25
-10.7%
Q1 25
19.2%
Q4 24
-189.9%
-3.4%
Q3 24
-153.4%
-8.1%
Q2 24
7.7%
Capex Intensity
HIVE
HIVE
RCMT
RCMT
Q1 26
Q4 25
Q3 25
0.7%
Q2 25
0.6%
Q1 25
0.5%
Q4 24
92.5%
1.3%
Q3 24
143.9%
0.9%
Q2 24
0.6%
Cash Conversion
HIVE
HIVE
RCMT
RCMT
Q1 26
3.11×
Q4 25
Q3 25
-0.56×
Q2 25
0.29×
-2.08×
Q1 25
3.98×
Q4 24
-0.42×
-0.57×
Q3 24
-26.94×
-1.58×
Q2 24
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons